Arthur R. McGivern - 01 Jan 2026 Form 3 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP, Investments & GC
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Arthur R. McGivern
Issuer symbol
RPRX
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
06 Jan 2026, 16:20:31 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McGivern Arthur Richard EVP, Investments & GC C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact for Arthur R. McGivern 06 Jan 2026 0002096372

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RPRX Class E Ordinary Shares 01 Jan 2026 Class A Ordinary Shares 706,393 $0.000000 See Footnote (1) F1
holding RPRX Restricted Share Units (RSU) 01 Jan 2026 Class A Ordinary Shares 24,441 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Class E ordinary share ("Class E Share") of Royalty Pharma Holdings Ltd ("RPH") will vest in installments over a 8-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.
F2 The RSUs vest quarterly as to 1/16th of the total RSUs underlying the original grant on October 11, 2022, subject to continued service through each vesting date.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney